APA (7th ed.) Citation

Aakash Mahant, Narcís Saubi, Yoshiki Eto, Núria Guitart, Josep Ma Gatell, Tomáš Hanke, & Joan Joseph. (2017). Preclinical development of BCG.HIVA2auxo.int, harboring an integrative expression vector, for a HIV-TB Pediatric vaccine. Enhancement of stability and specific HIV-1 T-cell immunity. Taylor & Francis Group.

Chicago Style (17th ed.) Citation

Aakash Mahant, Narcís Saubi, Yoshiki Eto, Núria Guitart, Josep Ma Gatell, Tomáš Hanke, and Joan Joseph. Preclinical Development of BCG.HIVA2auxo.int, Harboring an Integrative Expression Vector, for a HIV-TB Pediatric Vaccine. Enhancement of Stability and Specific HIV-1 T-cell Immunity. Taylor & Francis Group, 2017.

MLA (9th ed.) Citation

Aakash Mahant, et al. Preclinical Development of BCG.HIVA2auxo.int, Harboring an Integrative Expression Vector, for a HIV-TB Pediatric Vaccine. Enhancement of Stability and Specific HIV-1 T-cell Immunity. Taylor & Francis Group, 2017.